Positive News SentimentPositive NewsNASDAQ:NMTC NeuroOne Medical Technologies (NMTC) Stock Price, News & Analysis $0.69 -0.01 (-1.43%) Closing price 07/2/2025 04:00 PM EasternExtended Trading$0.69 +0.00 (+0.58%) As of 07/2/2025 06:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About NeuroOne Medical Technologies Stock (NASDAQ:NMTC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get NMTC alerts:Sign Up Key Stats Today's Range$0.68▼$0.7250-Day Range$0.56▼$0.7352-Week Range$0.40▼$1.39Volume92,303 shsAverage Volume186,320 shsMarket Capitalization$34.38 millionP/E RatioN/ADividend YieldN/APrice Target$1.45Consensus RatingBuy Company Overview NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota. Read More NeuroOne Medical Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks61st Percentile Overall ScoreNMTC MarketRank™: NeuroOne Medical Technologies scored higher than 61% of companies evaluated by MarketBeat, and ranked 426th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingNeuroOne Medical Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageNeuroOne Medical Technologies has only been the subject of 1 research reports in the past 90 days.Read more about NeuroOne Medical Technologies' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of NeuroOne Medical Technologies is -3.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NeuroOne Medical Technologies is -3.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNeuroOne Medical Technologies has a P/B Ratio of 23.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about NeuroOne Medical Technologies' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.42% of the float of NeuroOne Medical Technologies has been sold short.Short Interest Ratio / Days to CoverNeuroOne Medical Technologies has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NeuroOne Medical Technologies has recently decreased by 8.13%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNeuroOne Medical Technologies does not currently pay a dividend.Dividend GrowthNeuroOne Medical Technologies does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.42% of the float of NeuroOne Medical Technologies has been sold short.Short Interest Ratio / Days to CoverNeuroOne Medical Technologies has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NeuroOne Medical Technologies has recently decreased by 8.13%, indicating that investor sentiment is improving significantly. News and Social Media2.7 / 5News SentimentN/A News SentimentNeuroOne Medical Technologies has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies. Company Ownership1.7 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, NeuroOne Medical Technologies insiders have bought 2,593.48% more of their company's stock than they have sold. Specifically, they have bought $150,000.00 in company stock and sold $5,569.00 in company stock.Percentage Held by InsidersOnly 8.90% of the stock of NeuroOne Medical Technologies is held by insiders.Percentage Held by InstitutionsOnly 16.07% of the stock of NeuroOne Medical Technologies is held by institutions.Read more about NeuroOne Medical Technologies' insider trading history. Receive NMTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeuroOne Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address NMTC Stock News HeadlinesNeuroOne Medical Technologies Reports Successful Seizure-Free Milestone in First Patient Treated with OneRF® Ablation System - NasdaqJune 24, 2025 | nasdaq.comNeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation SystemJune 23, 2025 | globenewswire.comBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change. | Crypto 101 Media (Ad)NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate SecretaryJune 3, 2025 | globenewswire.comNeuroOne to Attend MedInvest’s MedTech, AI & Digital Health Conference on June 3-4, 2025May 29, 2025 | uk.finance.yahoo.comNeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025May 29, 2025 | globenewswire.comEarnings call transcript: NeuroOne Medical beats EPS expectations in Q1 2025May 15, 2025 | uk.investing.comNeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q2 2025 Earnings Call TranscriptMay 14, 2025 | msn.comSee More Headlines NMTC Stock Analysis - Frequently Asked Questions How have NMTC shares performed this year? NeuroOne Medical Technologies' stock was trading at $0.8259 at the beginning of 2025. Since then, NMTC shares have decreased by 16.5% and is now trading at $0.69. View the best growth stocks for 2025 here. How were NeuroOne Medical Technologies' earnings last quarter? NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) posted its quarterly earnings data on Tuesday, May, 13th. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.02. The company had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.27 billion. NeuroOne Medical Technologies had a negative net margin of 75.41% and a negative trailing twelve-month return on equity of 334.64%. Read the conference call transcript. How do I buy shares of NeuroOne Medical Technologies? Shares of NMTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of NeuroOne Medical Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that NeuroOne Medical Technologies investors own include Schwab US Large-Cap ETF (SCHX), NVIDIA (NVDA), Advanced Micro Devices (AMD), NIO (NIO), Ford Motor (F), Meta Platforms (META) and Plug Power (PLUG). Company Calendar Last Earnings5/13/2025Today7/02/2025Next Earnings (Estimated)8/13/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Services Sub-IndustryMedical Equipment Current SymbolNASDAQ:NMTC CIK1500198 Webwww.originalsourcemusic.com Phone(952) 426-1383FaxN/AEmployees20Year FoundedN/APrice Target and Rating Average Stock Price Target$1.45 High Stock Price Target$1.45 Low Stock Price Target$1.45 Potential Upside/Downside+110.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)($0.22) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$12.32 million Net Margins-75.41% Pretax Margin-75.40% Return on Equity-334.64% Return on Assets-124.42% Debt Debt-to-Equity RatioN/A Current Ratio2.13 Quick Ratio1.09 Sales & Book Value Annual Sales$3.45 million Price / Sales9.96 Cash FlowN/A Price / Cash FlowN/A Book Value$0.03 per share Price / Book23.00Miscellaneous Outstanding Shares49,820,000Free Float45,384,000Market Cap$34.38 million OptionableOptionable Beta0.66 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:NMTC) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.President Donald Trump made headlines last month with a staggering claim. He stated that since taking offic...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredConsumer apocalypse imminent (7 ominous red flags)The #1 Gold play right now (not a miner, ETF, or bullion) Gold is up 237% since 2008... but one gold invest...Stansberry Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroOne Medical Technologies Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroOne Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.